The Department of Veterans Affairs issued a Sources Sought Notice for fentanyl reagents, soliciting information from potential vendors capable of supplying these products. The notice, identified by solicitation number 36C26225Q0065, has a response deadline of October 25, 2024, at 9:00 AM Pacific Time. The notice indicates that the relevant Product Service Code is 6550 and the NAICS Code is 325413. Responses should be directed to Carlos Magana at the Network Contracting Office 22 in Long Beach, California. The place of performance for the contract is the VA Greater Los Angeles Healthcare System located on Wilshire Blvd, Los Angeles. The notice specifies no recovery act funds are involved and outlines relevant attachments that include a Request for Information (RFI) and a Statement of Work (SOW). This initiative highlights the VA's commitment to procuring necessary medical supplies as part of their operational requirements.
The government document outlines a Request for Proposal (RFP) concerning various diagnostic products related to fentanyl testing from Sekisui Diagnostic. It lists specific items including the Fentanyl II Assay kit, Fentanyl Control, Fentanyl Negative Calibrator, and Fentanyl Cutoff Calibrator, each accompanied by their respective manufacturer part numbers and quantity requirements. The document emphasizes the need for equivalent products that meet specified salient characteristics, as indicated in a separate Statement of Work (SOW). Pricing details for each item remain unspecified, indicating potential flexibility or pending evaluations. Overall, the RFP serves to procure essential diagnostic tools aimed at enhancing safety and regulatory compliance in healthcare settings, ensuring that equivalent quality materials are available for fentanyl detection.
The Statement of Work (SOW) outlines the requirements for vendor service and maintenance related to the procurement of Fentanyl reagents, calibrators, and controls for the Pathology & Laboratory Medicine Department at VA Greater Los Angeles Healthcare System (VAGLAHS). VAGLAHS is a key healthcare provider within the Desert Pacific Healthcare Network, offering diverse medical services and functioning as a reference lab for drug screening within VISN 22. The contract specifically seeks Fentanyl testing materials compatible with the Beckman Coulter AU 5800 system, including products from Sekisui Diagnostic. The vendor is expected to coordinate their service around VAGLAHS’s operational hours of 7:30 am to 5:00 pm, Monday through Friday, while recognizing federal holidays. This document serves as an essential guide for prospective vendors to understand the scope, expectations, and operational context associated with vitally needed laboratory supplies for effective patient care and safety within the VA system.
The Department of Veterans Affairs (VA), specifically the VISN 22 Network Contracting Office, has issued a Request for Information (RFI) to identify potential sources for Fentanyl reagents for the VA Los Angeles Beach Healthcare System. This RFI is part of a planning effort and does not constitute a solicitation. It invites responses from businesses, including Service Disabled Veteran Owned Small Businesses (SDVOSB) and others, to provide their qualifications, capabilities, and information that could inform future procurement decisions. Respondents must demonstrate their ability to meet the specifications laid out while clarifying their business size under the applicable NAICS code. They are instructed to submit details about their status as manufacturers or distributors, and any relevant federal contracts they hold. The responses should include information on whether the offered items meet necessary characteristics or if they are equal items. Notably, submissions must be received via email by October 25, 2024. This process helps the VA gauge market interest and readiness for future solicitations while ensuring compliance with federal procurement regulations.